Duke Energy Corp vs Medtronic PLC — how do they compare? Duke Energy Corp trades at $116.8 (market cap $91.10B), while Medtronic PLC trades at $87.87 (market cap $112.24B). The key difference: Medtronic PLC is the larger of the two by market cap, and Duke Energy Corp pays the higher dividend (3.71%). Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 74 Days and Medtronic PLC for 63 Days on average.
| DUK | MDT | |
|---|---|---|
Market Cap | $91.10B | $112.24B |
Volume | 4,199,050 | 105,663,236 |
Sector | Utilities | Health |
52-Week High | $133.46 | $105.35 |
52-Week Low | $113.23 | $73.75 |
Typical Hold Time | 74 Days | 63 Days |
Enterprise Value | $183.61B | $131.58B |
Dividend Yield | 3.71% | 3.28% |
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $115.5, down 0.14% on the day, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, revenue growth from $28.8B in 2022 to $32.2B in 2025, and a net income margin of 15.78%. Recent news highlights dividend stability and data center-driven growth opportunities, though rising Treasury yields pressure utility stocks.
DUK offers a balanced outlook with steady dividends and growth from data center demand, but faces risks from high debt levels and interest rate sensitivity. Analyst consensus is mixed with a $135.33 price target, suggesting 17% upside, supported by a 43.75% buy rating. Investors should weigh solid profitability against macroeconomic headwinds.
Medtronic (MDT) trades at $85.51, down 1.81% on the day, showing bearish technical signals despite strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending, while maintaining robust profitability margins of 65% gross and 14% net. Recent news highlights the company's 49-year dividend growth streak and new product approvals, though technical indicators show selling pressure with the stock trading near support at $85.
MDT presents a compelling value opportunity with a 3.2% dividend yield and 14% upside to the $97.80 consensus target, though near-term technical weakness and increasing debt levels warrant caution. The company's consistent earnings beats and medical device market leadership support long-term growth, while regulatory approvals for new systems provide catalysts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →